Key facts
- This page summarizes John E. Imhoff's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Jun 2023, 12:19.
John E. Imhoff - 01 Sep 2022 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- GTHP
- Reported as of
- 01 Sep 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Jun 2023, 12:19:44 UTC
- Next SEC filing
- 26 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E. Imhoff
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John E. Imhoff filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 26 Jun 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GTHP
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +500,000
- Change %
- +13%
- Price
- Shares after
- 4,356,532
- Date
- 02 Sep 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GTHP
transaction
Derivative
Warrants
Purchase
- Transaction value
- Shares
- +500,000
- Change %
- Price
- Shares after
- 500,000
- Date
- 01 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500,000
- Exercise price
- $0.5000
- Footnotes
- F1
GTHP
transaction
Derivative
Warrants
Purchase
- Transaction value
- Shares
- +500,000
- Change %
- Price
- Shares after
- 500,000
- Date
- 01 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500,000
- Exercise price
- $0.6500
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Imhoff pursuant to which the Company issued 500,000 shares of its common stock, four-year warrants to purchase an aggregate of 500,000 shares of common stock for $0.50 per share and four-year warrants to purchase 500,000 shares of common stock for $0.65 per share for an aggregate purchase price of $250,000.